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ABSTRACT OF THESIS 
 
 
 
FABRICATION OF AN EPITHELIAL CELL-BASED ION-SELECTIVE 
ELECTRODE AND ITS APPLICATION FOR USE AS ALTERNATIVE TUMOR 
ANGIOGENESIS ASSAY 
 
 
 
Previous studies have provided evidence that endothelial cell-based potassium 
ion selective electrodes possess the ability to quantify substances that have 
permeability-altering effects on those endothelial cells.  The capability of these 
so-called biosensors to detect elevated concentrations of certain chemical agents 
found following tumor formation make them useful in the application as an 
alternative tumor angiogenesis assay.  In this study an epithelial cell line, human 
colon adenocarcinoma epithelial cells (Caco-2), was used to fabricate 
membranes that were used to test concentrations of these chemical agents, 
known as cytokines, mimicking the concentrations that have been observed in 
the serum of healthy individuals as well as the higher concentration found in 
individuals with cancer.  Additionally background information is provided related 
to the development of whole cell-based biosensors, metabolic pathways related 
to tumor angiogenesis and the subsequent increase in cytokine concentration, 
properties of the Caco-2 cell line that make them useful for the application in cell-
based biosensors, and the ultimate effect the cytokines have on the permeability 
of the cells.   
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Chapter 1:  Introduction 
 
1-1 Summary of Previous Work 
In the recent past, whole-cell based biosensors have been used for the 
indirect quantification of toxins and other substances that are capable of altering 
cell permeability.  For example, it was found that when varying concentrations of 
histamine were exposed to a sensor with a barrier of human umbilical vein 
endothelial cells (HUVECs) attached and cultured on its surface, the permeability 
of the cells increased, which resulted in an increased response to potassium by 
the potassium-selective sensor.  In this way the concentration of the histamine 
could be determined by a linear correlation based on the response data of the 
cell-based potassium-selective electrode [1].  When exposed to varying 
concentrations of alpha toxin, the sensor returned a proportionate response to 
the varying concentrations of potassium ions, allowing the quantification of alpha 
toxin in samples by extrapolation [2]. When exposed to varying concentration of 
VEGF, a growth factor associated with angiogenesis during cancer, the 
permeability of cells increased and the sensor could be used as an indirect 
method for determining VEGF concentrations [3].  When exposed to cytokine 
solutions representative of serum of healthy individuals versus the serum of 
individuals with cancer, the biosensor detected a difference, thus demonstrating 
its potential as an alternative assay for angiogenesis [4].  By exposing this same 
cell-based biosensor to the actual serum of healthy individuals and individuals 
with varying stages of cancer, the biosensor proved to be effective in detecting a 
response indicative of the severity of condition of the individual [5]. 
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1-2 Research Objectives 
In previous experiments a potassium-selective cellulose triacetate 
membrane was used in conjunction with a specific line of endothelial cells.  
Studies demonstrating the in vitro absorption of experimental pharmaceutical 
chemicals utilize epithelial cells, for example T84 and Caco-2 cells because of 
their absorption properties have been found to be similar to the absorption 
properties within the human intestine.  Given the extensive amounts of 
information available on these cells as well as their consistent and good 
absorption properties, the studies pertaining to the use of a biosensor as an 
alternative assay of angiogenesis were continued with one of these epithelial cell 
lines, Caco-2.  In particular studies were completed to determine if a biosensor 
utilizing the Caco-2 cells could be used to differentiate between levels of 
cytokines indicative of healthy individual serum and the serum of cancerous 
subjects.   
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Chapter 2:  Background 
 
2-1 Biosensors 
2-1.1 Ion-Selective Electrodes 
Ion-selective electrodes are a type of analytical device used to measure 
the activity of specific ions in an aqueous solution.  Compared to other analytical 
tools, the ion-selective electrode is relatively inexpensive, durable, and versatile.  
An additional advantage is that measurement with an ion-selective electrode is 
not affected by color or turbidity of the aqueous solution [6].   For measuring the 
change in potassium ion activity in a sample solution, a setup including an 
indicator electrode, a reference electrode, a transducer, and a data acquisition 
unit is used (Figure 2-1).  As the activity of the analyte changes, the potential 
changes on the surface of the membrane of the indicator electrode.  It is not 
possible to directly measure this change in potential—instead it is measured 
relative to the reference electrode which maintains a constant potential with 
respect to the sample solution [7].  The change in potential is small and a 
transducer is necessary to amplify the signal into something that is measureable.  
The transducer may be potentiometric, voltammetric, conductometric, or field-
effect transistor-based [8]. For this study, a potentiometric transducer was used.  
The changing potential of the cell is monitored under theoretical zero current, 
achieved by using a high-impedance transducer. 
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Figure 2-1: Basic setup for measuring ions with ion-selective electrode 
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In the ideal situation, the potential of the cell is linearly related to the 
logarithm of the analyte’s activity, in a relationship dictated by the Nernst 
equation (Equation 1). 
 
       
  
  
  (  ) 
Equation 1 
 
EMF = electromotive force (or potential difference) 
E0 = standard cell potential 
R = ideal gas constant, 8.314 J K-1 mol-1 
T = absolute temperature, 298 K 
z = ionic charge of the ion of interest 
F = Faraday constant, 96,485 C mol-1 
a1 = activity of ion being measured 
For potassium, z = 1, and Equation 1 simplifies in the following ways: 
 
               ( )      
 
Equation 2 
 
           (  )       Equation 3 
 
The activity of a substance is related to its molar concentration according to 
equation 4.  
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          Equation 4 

1 = activity coefficient of species 
[x1] = molar concentration of species 
The potassium ion concentrations measured with the ion-selective 
electrode are small enough that the activity coefficient is assumed to remain 
constant for each concentration of potassium ions.  Under this assumption, the 
activity is linearly proportional to the concentration.  E0 is also constant so when 
the concentration of potassium ions increases from [K+]1 to [K
+]2, Equation 3 may 
be written as: 
 
         (  )   
     
     
 
Equation 5 
 
From the data acquisition unit the change in potential may be monitored.  
In a calibration plot, where the cell potential is plotted against the logarithm of the 
concentration of potassium ions, a linear relationship is expected and the slope 
of the resulting line should be 59.1 mV/decade (Figure 2-2).   
There are three underlying assumptions to the derivation of the Nernst 
Equation.  First, it is assumed that only the ion of interest passes through the 
membrane.  Second it is assumed that the concentration of the ion is appreciable 
at both interfaces of the membrane and also within the membrane.  Finally it is 
assumed that no concentration gradient exists at either interface of the 
membrane or within the membrane [9].  Given that the three assumptions are not 
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perfect, a perfect Nernstian slope is not always achievable.  For this study, a 
membrane has been classified as having a good response if it exhibits a 
response of 50 mV/decade or greater. 
Additionally the data point for 10-5M potassium consistently fell below the 
lower detection limit during this study, so although the EMF of that point was 
always recorded, it was not factored into the calculation of the slope.  Figure 2-3 
is a good example of an actual data set that demonstrates typical behavior of 
these membranes.  Two possible explanations exist to elucidate why membranes 
may deviate from Nernstian behavior at low concentrations.  One is that the 
membrane loses a small concentration of potassium ions which cancels out the 
effect of any influx of potassium ions from the sample solution.  The second 
possibility is that interfering ions affect the transport of potassium ions through 
the membrane and such interference is exaggerated at low concentrations of 
potassium ions [10].  
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Figure 2-2: Expected calibration curve exhibiting Nernstian behavior 
 
 
Figure 2-3: Sample calibration curve exhibiting actual data from fabricated 
membrane #32, section “C”, identified as 32(C)  
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2-1.2 Ion-Selective Membranes 
The final membrane that will be used here is composed of cellulose 
triacetate, potassium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (KTTFPB), 
valinomycin, and 2-nitrophenyl octyl ether (NPOE) and its purpose is to 
selectively detect potassium ions.  The membrane is asymmetric—it is composed 
of two layers with different compositions.  The first layer, which is ultimately in 
contact with the analyte solution, is composed of the polymer while the second 
layer contains the polymer and the active components that are responsible for 
ion detection.  Although the second layer on its own is sufficient for selectively 
monitoring potassium ions, the first layer is present so that the bioreagents may 
be attached covalently to the surface of the membrane after the first layer is 
hydrolyzed [11]. 
Cellulose triacetate (CTA) was used as the polymer matrix of the 
membrane.  The goal of the biosensor is ultimately to detect toxins in 
physiological samples, so formation of an electrode that is biocompatible is 
important.  Fibrin formation and clotting have been observed in polyvinyl chloride 
(PVC) membranes used in whole blood samples.  One method for reducing such 
undesirable behavior in blood samples is to attach heparin to the electrode’s 
membrane.  It has been documented that heparin attachment is more readily 
achieved on a CTA-based membrane when compared to a PVC-based 
membrane [12].  Because it is possible to achieve desirable electrode response 
whether CTA or PVC is used for the membrane’s polymer matrix, cellulose 
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triacetate is considered to be more ideal than PVC due to its potentially 
increased biocompatibility applications. 
Valinomycin is used in the membrane to facilitate transport of the 
potassium across the membrane.  Valinomycin is a neutral-carrier ionophore 
produced by the bacteria Streptomyces fulvissimus.  The structure of valinomycin 
is a macrocyclic ring, composed of 12 alternating amino acids and hydroxy acids.  
For clinical analysis of potassium concentration, valinomycin is the most 
commonly used ionophore [13]..  The frequent use of valinomycin is due to its 
high selectivity for potassium in comparison to other monovalent cations.  In fact 
the stability constant between valinomycin and potassium exceeds that of 
valinomycin and sodium by a magnitude of 105 [14].  It forms a complex with 
potassium ions when the oxygen from 6 of its carbonyl groups surrounds a single 
potassium ion.  Its large macrocyclic structure allows it to remain 
conformationally flexible even after complexation with a potassium ion.  This 
flexibility allows the valinomycin to quickly bind with the potassium ion at one 
interface of the membrane and quickly release the potassium ion at the opposite 
interface of the membrane [15].   
Potassium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (KTFFPB) is used 
to give the ion-selective membrane anionic sites necessary to exclude the 
counterion that may compete with the cation of interest for detection [10].  
Addition of the salt increases the membrane’s selectivity for potassium ions, 
decreases the electrical resistance of the membrane, and decreases the 
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response time of the electrode [16].  Figure 2-4 illustrates the formation of the 
valinomycin-potassium complex and also the added anionic exchanger sites. 
The final component of the membrane is a plasticizer.  To ensure 
sufficient ionic conductivity, it is necessary that the glass transition of the 
membrane be lower than room temperature [17].  The glass transition 
temperature (Tg) of CTA is 185.8 °C.  A plasticizer, in this case NPOE, is 
required to make the membrane more fluid.  
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Figure 2-4: Schematic of ionophore-cation complex and anionic exchanger 
sites in the membrane (adapted from [17]) 
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2-1.3 Utilizing Cells as Recognition Element 
The ion-selective membrane used in the ion-selective electrodes may be 
combined with some biological material to create a biosensor able to detect the 
presence of other biologically significant substances.  In previous studies human 
endothelial vein cells (HUVECs) were used as the biological material [1-5].  
Because a confluent layer of cells is nearly impermeable to many ions, growing 
cells onto the surface of an ion-selective electrode renders the electrode 
unresponsive to the ions.  When permeability-modifying substances are exposed 
to a confluent cell layer, the cells become more permeable and allow ions to pass 
through the cell layer via a few known existing mechanisms which will be 
discussed later in this paper. The electrode becomes more responsive in 
proportion to the change in the permeability of the cells, which is itself 
proportional to the amount of the permeability-modifying agent that was exposed 
to the cell layer as well as the amount of time it was exposed.  By maintaining 
constant exposure times, the amount of permeability-modifying substance that is 
present in a sample is proportional to how responsive the ion-selective electrode 
is to the ions. 
2-1.4 Cell Adhesion to Synthetic Membranes 
In order to attach cells to the membrane, some chemical modifications 
must be made to the membrane’s surface.  The ester group of the cellulose 
triacetate is hydrolyzed under basic conditions with sodium hydroxide (NaOH) to 
add hydroxyl groups under a saponification reaction (Figure 2-5).  Next a second 
layer containing the anion-repelling salt, the ionophore, and the plasticizer is 
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added to the untreated side of the membrane, and then the treated side of the 
first layer is exposed to a surface active agent, CDI, or carbonyldiimidazole 
(Figure 2-6). This allows RGD (Arginine-Glycine-Aspartic Acid) to be immobilized 
on the surface of the CTA membrane via the amide bond, and finally the cells are 
attached to the surface of the membrane through an interaction between the 
extracellular matrix and the peptide sequence (Figure 2-7).  
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Figure 2-5: Ester group is hydrolyzed with sodium hydroxide to add 
hydroxyl groups under a saponification reaction (adapted from [1]) 
 
 
Figure 2-6: Addition of a second layer to the membrane and the hydrolyzed 
side of membrane is exposed to a surface active agent (adapted from [1]) 
 
 
Figure 2-7: RGD is immobilized on the surface of the CTA membrane via 
the amide bond and cells are attached to surface of the membrane through 
the RGD peptide sequence (adapted from [1]) 
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2-2 Caco-2 Cells 
2-2.1 Differentiation and Proliferation 
 
The morphology of Caco-2 cells makes them an attractive candidate for 
modeling the absorption of pharmaceutical chemicals by in vitro methods.  Seven 
days after seeding Caco-2 cells at a cell density of 6 x 104 cells/cm2, a monolayer 
of poorly differentiated cells is formed, which is confirmed by a lack of 
tetramethylrhodamine (TRITC)-phalloidin staining of filamentous actin (F-actin) 
fibers.  By day 21, the cells are columnar in shape and are more strongly 
differentiated with a well-established brush border and by day 28 the cells reach 
a maximum level of confluency [18].  Caco-2 cells form structures similar to 
intestinal enterocytes, which allows the cells to be used as a model for mimicking 
the absorption of candidate oral pharmaceutical drugs through the human 
intestine [19-21].   
Although using Caco-2 cells is popular for the in vitro modeling of 
intestinal absorption, one disadvantage to their use are the lengthy culture times 
required for the cells to mature and form tight, nearly impenetrable monolayers.  
Allowing the cells to fully develop into useful, well-matured monolayers generally 
take approximately 3 weeks.  Some examples follow: 
When testing the permeability-altering effects of elevated glucose 
concentrations on Caco-2 cells, the cells were seeded with a density of 2.5 × 105 
cells/well (5.3 x 104 cells/cm2) and grown for a minimum of 21 days [22].  To 
evaluate the in vitro bioabsorption of aloe components, cells were seeded on 
transwell polyester membrane filters with a density of 6.4 x 106 cells/cm2 and 
were used in tests 14-21 days after the cells formed a confluent monolayer [23].  
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After Caco-2 cells were seeded onto transwell clear polyester membranes with a 
seeding density of 1 x 105 cells/cm2, the cells were reported to reach confluency 
within 3-4 days and were used 21-25 days to test the uptake and transport 
properties of propranolol [24]. Caco-2 cells were seeded in transwell plates with a 
density of 8 x 104 cell/cm2 and allowed to differentiate for 25 days before use in 
experiment to determine the effect of acetaldehyde on paracellular drug 
permeability [25].  
BD Biosciences (San Jose, CA) has created a method that it claims is 
capable of creating fully differentiated Caco-2 cell monolayers in only 3 days 
following seeding.  Its system includes specialized collagen-coated substrates, 
serum-free media, and cell-seeding density of 4.65 x 105 cells/cm2.  While the 
Caco-2 cell monolayers have been tested using this method and found to form a 
sufficient barrier for testing permeability, leakier cell monolayers were observed 
when compared to traditional 3 week Caco-2 permeability studies [26]. 
Other approaches to developing Caco-2 cell monolayers capable of rapid 
maturation and differentiation involve determining the most suitable range for 
passage numbers. At higher passage numbers, Caco-2 cells demonstrate an 
increased expression of P-glycoprotein (P-gp) protein, a cellular efflux pump, 
which results in greater accuracy and repeatability of permeability studies [27].  
In Caco-2 cells P-glycoprotein acts as a deterrent to the absorption of solutes.  It 
is present in the monolayer of Caco-2 cells but is not uniformly expressed.  The 
level of expression in the monolayer of cells determines how permeable the cell 
layer is [28]. 
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2-2.2 Predicting Intestinal Absorption 
After the cells have reached a suitable level of proliferation and 
differentiation, there are a variety of ways to test the integrity of the monolayer.  
One common method involves using a marker molecule, for example 
[14C]mannitol, which is allowed to passively diffuse across the barrier of cells, and 
the number of marker molecules that pass through are counted by liquid 
scintillation spectroscopy [29-33].  A similar method may be employed with 
fluorescent labeled marker molecules and quantified using a fluorescent 
spectrophotometer or fluorescent microscopy [33-36].  Perhaps the most 
common method for evaluating the barrier properties of the cell monolayer is by 
measuring the transepithelial electrical resistance, or TEER [30-32, 34-36].  To 
measure the TEER, cells are grown on filters in a specialized unit.  One electrode 
of a resistance meter is inserted in the apical chamber and one electrode is 
inserted in the basolateral chamber.  As the cell monolayer becomes more 
differentiated, the passive diffusion of ions between the chambers slows which 
results in an increase in the resistance across the cell layer [37]. 
2-3 Angiogenesis 
2-3.1 Angiogenic Switch 
 
Tumor cells face hypoxia when rapid cell proliferation results in the 
diameter of the tumor exceeding oxygen’s diffusion limit for transport from 
capillary blood vessels to cells.  Under these circumstances the tumor is able to 
sustain its growth by forming new, farther-reaching blood vessels, in a process 
called angiogenesis.  Vital to this activation of the “angiogenic switch” is a 
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transcriptional factor known as hypoxia-inducible factor (HIF-1), a heterodimer, 
consisting of alpha and beta subunits.  Under normoxic conditions, or when 
oxygen concentrations are normal, the proline residue on HIF-1 is hydroxylated.  
In addition to oxygen, this reaction requires iron, -Ketoglutarate, and ascorbic 
acid.  The product resulting from the expression of Von Hippel-Lindau (VHL) 
gene, Von Hippel-Lindau Protein, or pVHL, plays a role in the management of 
angiogenesis.  The prolyl hydroxylation results in the stabilization of HIF-1, 
allowing pVHL to bind to it.  While HIF-1 is present in all cell types under 
normoxic conditions, it is usually not detectable unless the cells are exposed to 
hypoxic conditions and then rapid accumulation of HIF-1 is observed with time 
[38]. 
2-3.2 Production of Cytokines 
This research focuses on the permeability-altering effects of 4 particular 
cytokines: 
 Vascular endothelial growth factor (VEGF) 
 Hepatocyte growth factor (HGF) 
 Basic fibroblast growth factor (bFGF) 
 Tumor necrosis factor alpha (TNF-) 
Under hypoxic conditions, the concentrations of all four of these cytokines 
of interest are increased in serum by a few chemical pathways.  Following the 
angiogenic switch, HIF-1 increases the expression of VEGF [39], HGF [40], and 
bFGF [41].  HIF-1 does not appear to be responsible for the accumulation of 
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TNF- during hypoxia.  Instead TNF- expression is increased by the 
transcription factor, Nuclear Factor Kappa B (NF-B) after it is activated during 
hypoxic conditions [42, 43].  The approximate concentrations of the cytokines 
found in the serum of healthy subjects as well as subjects with cancer are 
summarized in Table 2-1.  It has been assumed that each of the cytokines of 
interest would have a combined effect in an actual physiological environment, 
which would result in a more dramatic effect on Caco-2 cells when compared to 
isolated cytokines in a solution.  For this reason, the tests done during this study 
used elevated levels of cytokines to inflate the effects that the individual 
cytokines would have on the response of the cells.  These elevated levels are 
summarized in Table 2-2. 
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Table 2-1:  Mean Cytokine Concentrations Observed in the Serum of 
Healthy Subjects and Subjects with Cancer 
 
 Serum of Healthy Subjects 
Levels (pg/ml) 
Serum of Subjects with 
Cancer Levels  (pg/ml) 
VEGF 122.8 – 201.7 [44] 331.5 – 831.4 [44-46] 
mean = 331.5, 360.0,  295.7, 
833.4  (Stage I, II, III, and IV 
breast cancer, respectively) 
[44] 
 
479 + 461 (metastatic 
colorectal, breast, ovarian, 
renal carcinoma) [45] 
 
564.5 ± 147.88 (breast 
carcinoma) [46] 
 
 
 
bFGF 0 – 4.93 [47] 6.64 – 11.4 [45, 47] 
11.4 + 10.6 (metastatic 
colorectal, breast, ovarian, 
renal carcinoma) [45] 
 
mean = 6.64 (prostatic 
carcinoma) [47] 
HGF 343.00 [48] 529.05 [48] 
529.05 ± 123.33 (breast 
carcinoma) [48] 
TNF- 5.2 [46] 28.6 [46] 
28.6 ± 7.99 (breast carcinoma) 
[46] 
 
  
 
22 
 
Table 2-2: Cytokine Concentrations Used in this Experiment to Represent 
Normal Levels of Cytokines and Elevated Levels of Cytokines 
 
 Serum of Healthy Subjects 
Levels (pg/ml) 
Serum of Subjects with 
Cancer Levels  (pg/ml) 
VEGF 100 1000 
bFGF 5 40 
HGF 100 1000 
TNF- 10 100 
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2-3.3 Cytokine Effects on Cell Permeability 
The cytokines related to angiogenesis affect the permeability of Caco-2 
cells, as well as other epithelial cells, by inducing changes in the morphology of 
the structures that join neighboring cells.  Between the cells in a layer are 3 types 
of cell junctions: 
 Adherens junctions 
 Gap junctions 
 Tight junctions 
Adherens junctions composed of two different types of proteins:  
cadherins and catenins.  Cadherins are calcium-dependent cell adhesion 
molecules that are linked to the cytoskeleton of cell through catenins.  There are 
various types of cadherins and they are named according to where they are 
located.  For example, cadherin located in retinal cells is referred to as R-
cadherin, while the cadherin found in epithelial cells is called E-cadherin. 
Gap junctions are cell junctions that are specialized for intercellular 
communication.  They are composed of one type of protein: connexin.  
Connexins are made of 6 subunits arranged around an annulus.  Gap junctions 
are gated—at least one of the connexin’s subunits is believed to close the 
junctions in situations when certain ions become elevated within the cells. 
Tight junctions are located between adjacent epithelial cells, apically 
relative to the rest of the cell junctions of the junctional complex.  Tight junctions 
are composed of two different types of proteins:  occludins and claudins.  The 
strength of the adhesion between the cells via tight junctions is related to the type 
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of these proteins within the tight junctions.  Occludin is composed of two peptide 
sequence loops which are responsible for the tight junctions’ adhesive properties.  
The effectiveness of the barrier between cells is compromised when a synthetic 
peptide sequence mimicking one of these loops is introduced to a cell layer [49].  
Additionally, when occludin is expressed in Madin-Darby Canine Kidney (MDCK) 
cells, the integrity of the cell monolayer is improved [50]. 
It has been shown that the phosphorylation of certain proteins in the 
junctional complex can lead to the reduction of the adhesive properties between 
cells [51-53].  When exposed to HGF MDCK cells developed newly 
phosphorylated E-cadherin [54].  When Caco-2 cells were exposed to TNF-, the 
occludin protein became more phosphorylated, resulting in the observation of the 
decrease in the transepithelial resistance between the cells.  In fact after 
exposing the cells to TNF-, a change in morphology between the cells was 
observed, including a reduction in the number of tight junctions as well as 
enlarged spacing between the cells [55].  It has been demonstrated that VEGF 
phosphorylates connexin 43 in the gap junctions of a human umbilical vein cell 
line’s (Ea.hy926) cells [56].  Downregulation of cadherins has been observed in 
the presence of bFGF in HUVEC cells [57]. 
 Changes in the cell junction morphology cause changes to the 
paracellular permeability of the cells.  Altering the cell junctions allow solutes to 
pass between neighboring cells, driven by passive diffusion from higher 
concentrations to lower concentrations.  In this research 2 sets of experiments 
were performed.  In the first experiment, the cytokines’ effects on paracellular 
 
25 
 
gap area were tested and the impact on paracellular permeability was explored.  
In the second experiment, the effects of the cytokines on the responsiveness of a 
cell-based electrode were tested and changes were expected via a combination 
of each pathway.  Figure 2-8 illustrates the difference between these two 
pathways.  
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Figure 2-8: Demonstration of two main pathways for solutes to travel 
across a cell monolayer [58] 
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Chapter 3:  Experimental Materials 
 
3-1 Membrane Fabrication 
Celluose triacetate (Cat. # 181005), Selectophore™ grade Tetrakis[3,5-
bis(trifluoromethyl)phenyl]boron potassium (Cat. # 60588), Selectophore™ grade 
Valinomycin (Cat. # V0627), Selectophore™, grade, ≥99.0% 2-Nitrophenyl octyl 
ether (Cat. # 73732), CHROMASOLV®, grade for HPLC, ≥99.8% Chloroform 
(Cat. # 366927), reagent grade, ≥98.0% Tetrachloroethane (Cat. # 185434), ACS 
reagent, ≥99.5% Dichlormethane (Cat. # D65100), and reagent grade, ≥98% 
Sodium hydroxide pellets (Cat. # S5881) were obtained from Sigma-Aldrich (St. 
Louis, MO).   
3-2 Testing Membranes 
≥99.0% Potassium chloride (Cat. # P5405), reagent grade, ≥99.0% 
(titration) Trizma® hydrochloride (T3253), and ≥99.9% (titration) Trizma® base 
(T1503) were obtained from Sigma-Aldrich (St. Louis, MO).  
3-3 Treatment of Caco-2 Cells 
3-3.1 Culturing Caco-2 Cells 
 
Caco-2 cells at passage 20 (Cat. # HTB-37), Fetal Bovine Serum, or FBS, 
(Cat. # 30-2020), and Eagle's Minimum Essential Medium (Cat. # 30-2003) were 
obtained from American Type Culture Collection (ATCC, Manassas, VA).  The 
medium contained Earles Balanced Salt Solution, non-essential amino acids, 2 
mM L-glutamine, 1 mM sodium pyruvate, and 1500 mg/L sodium bicarbonate 
and was supplemented with Fetal Bovine Serum to a final concentration of 20%. 
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3-3.2 Subculturing Caco-2 Cells 
Trypsin Ethylenediaminetetraacetic Acid, or Trypsin-EDTA, (0.25%-
0.53mM) in Hanks Balanced Salt Solution was obtained from American Type 
Culture Collection (Manassas, VA).   
3-3.3 Attaching Caco-2 Cells to Membrane 
Glycine-Arginine-Glycine-Aspartic Acid-Serine (GRGDS) (Cat. # H-1345) 
was obtained from Bachem (Torrance, CA).  ≥99.85% Glacial acetic acid (Cat. # 
695084), ReagentPlus® grade, ≥99.5% Sodium carbonate (Cat. # S-2127), 99.5-
100.5%  Sodium bicarbonate (Cat. # S-5761), ReagentPlus® grade, ≥99.0% 
Sodium acetate trihydrate (Cat. # S-8625), and ≥97.0% (T) 1,1′-
Carbonyldiimidazole (Cat. # 21860) were obtained from Sigma-Aldrich (St. Louis, 
MO).  
3-3.4 Permeability Studies 
Carrier-free recombinant human VEGF165 (Cat. # 293-VE-010/CF), HGF 
(Cat. # 294-HGN-005/CF), TNF- (Cat. # 210-TA-010/CF), bFGF (Cat. # 233-FB-
025/CF) were obtained from R&D Systems (Minneapolis, MN).   
3-3.5 Freezing Caco-2 Cells for Storage 
Hybri-Max™ grade, ≥99.7% filter-sterilized Dimethyl sulfoxide, DMSO, 
(Cat. # D2650) was obtained from Sigma-Aldrich (St. Louis, MO). 
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Chapter 4: Experimental Methods 
 
4-1 Membrane Fabrication 
 
To make the cocktail for the 1st layer of the membrane, 74 + 0.2 mg of 
Cellulose triacetate was dissolved overnight at ambient conditions in 1.1 ml of 
dichloromethane, 0.4 ml of chloroform, and 0.4 ml of tetrachlorethane.  To form a 
seal to prevent leakage, approximately 0.5 ml of the 1st layer cocktail was applied 
around the inner edge of a 31 mm ID glass ring resting on a piece of Teflon.  
After approximately 1 minute, the remainder of the 1st layer cocktail was added to 
the 31 mm ID glass ring.   A Teflon plate was placed on top of the glass ring and 
the solvents were allowed to evaporate for at least 48 hours through venting 
grooves cut into the glass ring.  After the solvents evaporated, the membrane 
was removed from the glass ring and the side formerly in contact with Teflon was 
hydrolyzed in 1.0M NaOH for 4.5 hours.  During the casting process, the 
membrane formed raised edges and this ensured that only one surface of the 
membrane contacted the NaOH.  After hydrolysis, the membrane was rinsed 
thoroughly with DI Water, patted dry with a KimWipe, and placed hydrolyzed-side 
down on a piece of Teflon.  A 25 mm ID glass ring was placed in the center of the 
membrane and the 1st layer was allowed to dry completely overnight.   
To make the cocktail for the 2nd layer of the membrane, 34 + 0.1 mg of 
Cellulose triacetate, 1 mg of Valinomycin, 0.42 mg of KTTFPB were dissolved 
overnight at ambient conditions in 0.8 ml of dichloromethane, 0.8 ml of 
chloroform, and 0.1 ml of NPOE.  To form a seal to prevent leakage, 
approximately 0.5 ml of the 2nd layer cocktail was applied around the inner edge 
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of the 25 mm ID glass ring resting on the 1st layer of the membrane.  After 
approximately 1 minute, the remainder of the 2nd layer cocktail was added to the 
25 mm ID glass ring.  The solvents were allowed two days to dry from the second 
layer and the second layer fused with the first layer to form a single asymmetric 
membrane. 
4-2 Testing Membranes 
Each membrane was sectioned into five 6 mm discs using a cork borer.  
One section per each fabricated membrane was used as the control to determine 
how other membrane sections would respond before cells were grown on a 
section’s surface.  The membrane section was conditioned in 0.01M potassium 
chloride (KCl) after it was placed in a membrane housing piece in an orientation 
so that the hydrolyzed surface was in contact with the conditioning solution.  The 
membrane was conditioned for 24 hours in the KCl solution0 to allow an 
equilibrium to establish within the membrane.  Then the membrane housing 
piece was attached to an electrode body with 0.01M KCl filling solution.  The 
electrode, along with a reference electrode, was placed in 50 ml of 0.1M 
Tris(hydroxymethyl) aminomethane (Tris) buffer that was stirred slowly with a stir 
bar.  To the sample solution, the following quantities of KCl were serially added: 
5 l of 0.1M KCl, 50 l of 0.1M KCl, 50 l of 1.0M KCl, 500 l of 1.0M KCl, and 
5.6 ml of 1.0M KCl.  These additions changed the potassium concentration of the 
sample solution from 0M to 10-5M, 10-4M 10-3M, 10-2M, and 10-1M and the EMF 
was recorded at each concentration.  A plot was made of the EMF vs. the 
logarithm of the potassium concentration and the slope was calculated for the 
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last 4 data points.  If the slope was greater than 50 mV/decade, then the 
membrane’s performance was considered to be sufficiently responsive and small 
sections of the membrane was saved for use in further tests.  
4-3 Treatment of Caco-2 Cells 
4-3.1 Culturing Caco-2 Cells 
 
Upon receipt, the cryovial containing the frozen Caco-2 cells was rapidly 
thawed by submersion in a water bath maintained at 37°C.  Under a sterile 
laminar flow hood, the contents of the vial were transferred to a 15 ml centrifuge 
tube containing 9 ml of complete culture medium.  The cells were spun down in a 
centrifuge for 5 minutes and the supernatant was discarded.  The cells were 
resuspended in 15 ml of complete medium and transferred to a 75 cm2 culture 
flask with a vented cap.  The cells were incubated at 37°C in 5% CO2.  The 
media was replenished twice per week until the cells formed a confluent 
monolayer on the surface of the culture flask. 
4-3.2 Subculturing Caco-2 Cells 
After the cells reach confluency, the media of the culture flask was 
discarded.  20 ml of heat-sterilized phosphate buffered saline (PBS) solution was 
added to the flask and incubated at 37°C for 4 minutes to remove serum and 
Ca2+ that inhibit the Trypsin-EDTA.  The sterile PBS solution was then removed 
and discarded and 5 ml of Trypsin-EDTA was added to the flask.  The flask was 
incubated at 37°C for 15 minutes or until the cell layer detached from the culture 
flask.  7 ml of complete growth medium was added to the culture flask and the 
cells were gently aspirated by pipetting.  The cell solution was divided equally 
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into four 15 ml centrifuge tubes and spun down in a centrifuge with a swing-out 
rotor assembly for 5 minutes.  The supernatant was removed and discarded and 
the cells were cultured in a new flask or well plates, attached to test membranes 
for experimentation, or added to freezing solution for storage in liquid nitrogen.  
4-3.3 Counting Caco-2 Cells 
Cell counts were performed using a hemocytometer.  First the media was 
removed from the stationary flask and discarded.  Next the cells were rinsed with 
10 ml PBS to remove any residual serum.  Then the cells were exposed to 9 ml 
of Trypsin-EDTA to detach the cells from the flask.  The cell solution was split 
into 3 centrifuge tubes and spun down to separate the Trypsin-EDTA from the 
cell pellet.  The Trypsin-EDTA was removed with a pipette and discarded.  To the 
centrifuge tubes 45 ml of growth media was added and the cells were mixed 
thoroughly by gentle aspiration with a pipette.  The cell solution was further 
diluted by withdrawing 1 ml of dilute cell solution and adding it to 3 ml of growth 
media.  A couple of drops of this solution were added to a hemocytometer, so 
that the face was completely flooded.  Under a microscope with a 10x exposure, 
the numbers of cells within the boxes depicted in white in Figure 4-1 were 
counted and the average per square grid was taken.  An image of one square 
grid with cells is shown in Figure 4-2.  The number of cells per volume of original 
mixture could be calculated from Equation 7.   
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Figure 4-1: Schematic of square grids of a hemocytometer.  The white 
squares represent the area where cells were counted. 
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Figure 4-2: 10x microscope image of a single square grid of 
hemocytometer loaded with Caco-2 cells. 
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4-3.4 Attaching Caco-2 Cells to Membrane 
Up to five 6 mm discs may be obtained from the membrane.  After the 
control membrane was confirmed to perform satisfactorily, four more sections 
were cut from the membrane.  Before the sections could be cut, they needed to 
be prepared for cell attachment.  The remaining untested portion of the 
membrane was floated in 20 ml of refrigerated DI water with the hydrolyzed side 
in contact with the water.  Approximately 0.34 g of carbonyldiimidazole was 
added to the beaker in five increments of 3 minutes.   The membrane was then 
rinsed with refrigerated DI water and floated in a 50-ml glass beaker containing 3 
ml of 0.1M sodium carbonate and 1.5 mg of GRGDS peptide.  The beaker was 
placed in an incubator shaker set at 25°C and 100 rpm for approximately 24 
hours.  Afterwards, the membrane was rinsed for a few minutes in 0.1M sodium 
bicarbonate followed by a brief submersion in DI water.  It was then rinsed for a 
few minutes in 0.1M sodium acetate that has been adjusted to pH 4 with acetic 
acid.  It was again submerged briefly in DI water and then left under a UV light in 
a hood to be sterilized overnight.  The following day the remaining sections of the 
membrane were cut using the cork borer and placed in the membrane housing 
pieces.  The membrane sections were then conditioned for 24 hours in 0.1M KCl 
that has been sterilized by autoclaving. 
The cells, which have reached confluency in the culture flask by this point, 
were split into 3 centrifuge tubes, counted using a hemocytometer, and then 
diluted to a final concentration of approximately 4.7 x 106 cells/ml.  2 ml of the 
diluted cell suspension is added directly to the surface of the membrane, which is 
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still in the membrane housing piece.  The membrane housing piece is then 
placed in an incubator for 72 hours while the cells grow into a confluent layer on 
the membrane’s surface.  
4-3.5 Freezing Caco-2 Cells for Storage 
Between experiments, the unused Caco-2 cells were frozen and stored for 
use in future tests.  In order to freeze the Caco-2 cells for storage, a mixture 
consisting of 95% complete growth medium and 5% filter-sterilized DMSO was 
made.  The cells in a stationary flask were split into 3 centrifuge tubes, using the 
previously described method for subculturing the cells.  To each centrifuge tube, 
2 ml of freezing solution was added and each centrifuge tube was split into 2 
cryovials.  The cryovials were frozen overnight at -80°C and then stored in a 
cryotank of liquid nitrogen. 
4-4 Testing Permeability Effects of Cytokines 
4-4.1 Paracellular Gap Area 
 
The method for determining the area resided by cells using computer-
assisted image analysis has been briefly outlined [59].   
In 24 well plates Caco-2 cells were cultured until they reached confluency.  
The media was disposed and each well was rinsed with 2 ml of sterile PBS.  
After shaking, the PBS solution was removed from each well and disposed of.  
The cells were exposed to the various test agents and incubated at 37°C for 1 
and 3 hours.  Following incubation, the test agent was removed from each well 
and discarded.  To each well, 1 ml of 3% paraformaldehyde (PFA) was added to 
the cells and the cells were fixed under a sterile laminar flow hood at ambient 
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conditions for 30 minutes.  The cells were rinsed with 2 ml of sterile PBS two 
additional times.  The cells were stained with Coomassie blue solution for 10 
minutes.  The cells were rinsed with sterile PBS solution multiple times until the 
excess dye was removed and the discarded PBS was clear in color.  The cells 
were allowed to dry under ambient conditions for approximately 30 minutes.   
Images were captured of each well plate under an inverted phase contrast 
microscope at 320x and 50 ms exposure time using AxioVision4.  All images 
were converted to Tagged Image File Format (Tiff) files and analyzed with Scion 
Image.  Upon 16x magnification, the threshold pixel was selected to correspond 
to the area just outside the edge of an individual cell.  The image was then 
converted to a binary image and the image was inverted, so that the white pixels 
corresponded to the gaps and the black images corresponded to the cells.  A 
histogram was given for each selection and from that histogram, the number of 
white pixels as well as the total number of pixels could be determined.  The 
paracellular gap area was then expressed as a ratio of the number of white pixels 
to the total number of pixel values in a given selection (Equation 8). 
 
                         
                
                         
        Equation 8 
 
For each image, 4 selections were made for calculating 4 different 
paracellular gap areas per each well.  
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4-4.2 Electrode Response 
After 3 days of incubation, the inhibition of response of the electrode is 
tested to ensure the cells have formed a confluent layer on its surface.  After 
each addition of KCl, the EMF value is recorded.  The ion-selective electrode 
response slope is the slope of these EMF values versus the logarithmic molarity 
of potassium.  The ion-selective electrode response of the test membrane is 
divided by the ion-selective electrode response of the control membrane to give a 
ratio. In the past a ratio of approximately 0.05 was observed for the response of 
electrodes with a confluent layer of cells when compared to the response of an 
electrode without cells.  A ratio equal to or less than 0.05 was considered to be 
indicative of a well-developed cell layer on the surface of the electrode.  Each 
time cells were attached to a set of membranes, at least one membrane was 
randomly selected and the integrity of its cell monolayer was tested.  This 
provided an approximation of the degree of confluency of the cell monolayer for 
each of the remaining membranes.  To test the integrity of the cell monolayer, the 
membrane was attached to an electrode and its response to changes in the 
potassium ion concentration was measured.  A low response (change in EMF 
less than 10% of the change in EMF for the control or “cell free” membrane) was 
considered indicative of a confluent monolayer of cells on the surface of the 
membrane.  If a low response was observed, the remaining membranes were 
used in permeability tests (due to a problem with the read-out of the transmitter, 
the integrity of the cell monolayer was tested but the integrity could not be 
quantified on 7/12/09).   
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To perform permeability tests, first the media was removed from the filter 
house set-up.   In its place, a cytokine mixture was exposed to the cells on the 
membrane.  The membranes were returned to the incubator for 3 hours.  
Following 3 hours, the membranes were rinsed with DI water, placed on 
electrodes, and their response relative to the response of the control or “cell free” 
membrane was evaluated. 
 
  
 
41 
 
Chapter 5: Discussion 
 
5-1 Results 
 
When faced with hypoxia, a tumor is able to access points of higher 
oxygen concentration by forming a more extensive network of blood vessels.  
This process is known as angiogenesis and is responsible for the increased 
production of VEGF, HGF, bFGF, and TNF- in the blood stream of individuals 
with cancer. The purpose of this research was to develop a method using a 
Caco-2 cell-based biosensor as an indicator for angiogensis by distinguishing 
between the normal levels of cytokines typical of a healthy individual and 
elevated levels of cytokines.  
As mentioned earlier, there have been many permeability studies 
performed with the Caco-2 cell line, specifically because of the cells’ good 
absorption properties.  The ability of the cells to form a confluent and virtually 
impenetrable surface on the surface of an ion-selective electrode’s membrane 
was a crucial property to make this research possible.  The level of confluency 
was judged visually by optical microscopy using a 10x lens objective.  Figure 5-1 
and 5-2 demonstrate the level of confluency achieved 3 and 6 days following 
seeding the flasks.  When the cells were introduced to VEGF, HGF, bFGF, or 
TNF-, a disruption to the cell monolayer occurred, resulting in the electrode 
demonstrating an increased response to the presence of potassium ions.   
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Figure 5-1: Caco-2 cells 3 days post-seeding (2 cells have been circled) 
 
 
Figure 5-2: Caco-2 cells 6 days post-seeding (2 cells have been circled) 
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Before testing of the effects of cytokines on the Caco-2 cell-based 
biosensor could be initiated, the possibility that any observable effects of 
cytokines on the cell-based biosensor were actually due to effects of the 
cytokines on the permeability of the membrane itself was excluded.  Previous 
studies with endothelial cell lines have established that when the four cytokines 
of interest are exposed to the membrane of the electrode, they have no effect on 
the electrode’s response unless cells are present [4].  In other words, any 
observable difference between the electrode response behavior of the control 
membranes and the test membranes is attributed to the effects of the cytokines 
on the cells and not to changes of permeablilty in the polymer membrane itself. 
During the planning of the experiment, a decision had to be made as to 
how long the cytokine exposure time would be for the cells on the membrane.  
The process of making and preparing the membranes was time-consuming and 
tedious due to the multi-stepped nature of the process, so a screening test was 
necessary to avoid wasting time and materials.  This was the purpose of the 
paracellular gap area imaging.  This screening test was performed in 24 well 
plates at a time, allowing for 24 different conditions to be tested in a single pass. 
This made it possible to test quickly both normal levels as well as elevated levels 
of all four cytokines as well as test the two potential exposure times of one and 
three hours.  The technique of capturing images under an inverted phase 
contrast microscope, as well as the method of processing the images, was also 
quick and easy; allowing the entire screening test to be completed within a day 
after the cells reached confluency in the well plates.  After exposing the cells to 
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cytokines in a well plate for three hours, a greater disparity in the gaps between 
the cells was observed with the cells that were exposed to normal levels of 
cytokines versus elevated levels of cytokines was observed when compared to 
the one hour exposure time (Figure 5-3 and 5-4).  This was especially true in the 
case of HGF.  For this reason, three hours was selected as the exposure time for 
testing the response of the cells to cytokines after they were grown on the 
electrode’s membrane. 
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Figure 5-3: Percent paracellular gap area following one hour of exposure to 
normal levels of cytokines and elevated levels of cytokines (Error bars 
represent +/- 1 standard deviation N = 12).  
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Figure 5-4: Percent paracellular gap area following three hours of exposure 
to normal levels of cytokines and elevated levels of cytokines (Error bars 
represent +/- 1 standard deviation N = 12). 
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The paracellular gap area test was a good indication of how the electrodes 
would respond to cytokines and therefore it was a useful screening tool.   
Figures 5-5 through 5-13 demonstrates the electrode response data that 
was collected for cell-attached membranes not exposed to cytokine mixture (i.e. 
“Cells Only”), for cell-attached membranes exposed to normal and elevated 
levels of each cytokine for 3 hours, and for the corresponding membrane each 
membrane section corresponds to that was neither cell-attached nor exposed to 
cytokine mixture (i.e. “Control”). 
Following a three hour exposure to the cytokine solutions, a significant 
difference in electrode response between the cells that were exposed to a low 
concentration of cytokines and the cells that were exposed to a high 
concentration of cytokines was observed (Figure 5-14).  Table 5-1 summarizes 
the test results of all membrane sections that were used and tested during the 
generation of the data in the electrode experiment. 
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Figure 5-5:  Electrode response data for cell-attached membranes not 
exposed to cytokine mixture (i.e. “Cells Only”) 
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Figure 5-6: Electrode response data for cell-attached membranes exposed 
to a normal level of HGF for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-7: Electrode response data for cell-attached membranes exposed 
to an elevated level of HGF for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-8: Electrode response data for cell-attached membranes exposed 
to a normal level of VEGF for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-9: Electrode response data for cell-attached membranes exposed 
to an elevated level of VEGF for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-10: Electrode response data for cell-attached membranes exposed 
to a normal level of bFGF for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-11: Electrode response data for cell-attached membranes exposed 
to an elevated level of bFGF for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-12: Electrode response data for cell-attached membranes exposed 
to a normal level of TNF- for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-13: Electrode response data for cell-attached membranes exposed 
to an elevated level of TNF- for 3 hours as well as for the corresponding 
membrane each membrane section corresponds to that was neither cell-
attached nor exposed to cytokine mixture (i.e. “Control”) 
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Figure 5-14: Electrode response ratio following three hours of exposure to 
a normal level of cytokines and an elevated level of cytokines (Error bars 
represent +/- 1 standard deviation N = 5 for “Cells only”, N = 4 for Elevated 
Levels of bFGF and HGF, N = 3 otherwise).  
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Table 5-1: Summary of Membranes Used and Data Collected 
Date Membrane Electrode Response Slope R2 Conditions 
6/3/2008 52(A) 54.91 1.00 Control 
6/5/2008 54(A) 55.47 0.97 Control 
6/29/2008 52(B) 13.7 0.89 Cells only 
6/29/2008 54(B) 4.41 0.96 Cells only 
2/21/2009 75(A) 56.95 0.98 Control 
3/22/2009 75(C) 12.59 0.92 Elevated bFGF #1 
3/22/2009 76(D) 1.90 0.96 Cells only 
4/8/2009 84(A) 55.62 0.99 Control 
4/8/2009 85(A) 61.6 0.97 Control 
4/8/2009 87(A) 60.07 0.97 Control 
4/8/2009 88(A) 51.1 0.98 Control 
7/12/2009 84(E) 5.17 0.99 Normal hGF #1 
7/12/2009 85(B) 5.43 0.97 Normal hGF #2 
7/12/2009 85(C) 4.9 0.98 Normal VEGF #1 
7/12/2009 85(D) 12.26 0.99 Normal VEGF #2 
7/12/2009 85(E) 12.44 0.98 Normal TNF- #1 
7/19/2009 87(B) 2.5 0.95 Cells only 
7/19/2009 87(C) 8.09 0.99 Normal TNF- #2 
7/19/2009 87(D) 8.85 0.97 Normal TNF- #3 
7/19/2009 87(E) 10.95 0.99 Normal VEGF #3 
7/19/2009 88(B) 6.82 0.97 Normal hGF #3 
7/19/2009 88(C) 3.51 1.00 Normal bFGF #1 
7/19/2009 88(D) 4.03 0.95 Normal bFGF #2 
7/19/2009 88(E) 3.89 0.98 Normal bFGF #3 
8/2/2009 90(A) 52.4 0.99 Control 
8/2/2009 91(A) 50.8 0.98 Control 
8/2/2009 92(A) 55.25 0.96 Control 
8/2/2009 93(A) 51 0.99 Control 
9/13/2009 90(B) 3.79 0.92 Cells only 
9/13/2009 90(C) 12.55 0.94 Elevated bFGF #2 
9/13/2009 90(D) 13.77 1.00 Elevated bFGF #3 
9/13/2009 90(E) 14.5 0.95 Elevated bFGF #4 
9/13/2009 91(B) 17.31 0.95 Elevated VEGF #1 
9/13/2009 91(C) 17.6 0.95 Elevated VEGF #2 
9/13/2009 91(D) 8.78 0.95 Elevated hGF #1 
9/13/2009 91(E) 9.38 0.99 Elevated hGF #2 
9/27/2009 92(B) 2.44 0.96 Cells only 
9/27/2009 92(C) 17.2 1.00 Elevated VEGF #3 
9/27/2009 92(D) 10.4 0.99 Elevated hGF #3 
9/27/2009 92(E) 15.73 0.96 Elevated TNF- #1 
9/27/2009 93(B) 16.81 0.99 Elevated TNF- #2 
9/27/2009 93(C) 15.15 0.96 Elevated TNF- #3 
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In both the gap area test and the electrode test, there was a clear 
difference between the cells that were exposed to a low level of cytokines and 
the cells that were exposed to a high level of cytokines.  Although results from 
the gap area study suggested that of all of the four cytokines, bFGF played the 
most significant role in increasing the spaces between the epithelial cells, both 
TNF- and VEGF had a greater impact on the cell-to-cell adhesion when tested 
on the electrode.  Although this may be due to the crude nature of the gap area 
method and interpretation of results, a second explanation is that the 
permeability of the cells in controlled by transcelluar pathways in addition to 
paracellular pathways.  One possibility for the discrepancy between the changes 
in permeability seen in percent paracellular gap area calculations and the 
electrode response measurements could be due to the possibility that the 
percent paracellular gap area calculations only take into account changes in the 
paracellular pathways and not changes in the transcellular pathways.  On the 
other hand, the electrode measurements may be affected by changes in both 
paracellular and transcellular pathways.  The notion that solutes may travel 
through the cells and between the gaps in the cell monolayer could also explain 
why there were only small gaps between the cells that were not exposed to 
cytokines but still demonstrated a notable response to potassium ions on the 
electrode.  There were some inconsistencies in how much resistance the 
membranes with cells that were not exposed to cytokines demonstrated.  
Although this resulted in cell-only membranes with responses higher than the 
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established standard, the subsequent results were saved because cell-based 
membranes exposed to the elevated levels of cytokines still maintained a much 
higher response in comparison.   
5-2 Future Work 
 
Some improvements may be made to decrease the waste of time and 
materials in the membrane fabrication process, improve the inhibition of 
response for the cell-only control membrane-based biosensors, possibly reduce 
the standard error of the repeats and better understand the mechanisms involved 
with the permeability changes.  Future work may include:  
 Investigating better membrane fabrication methods 
 Altering the culture conditions 
 Utilizing other epithelial cell lines 
 Exploring the mechanisms of permeability changes in cells 
5-2.1 Investigating better membrane fabrication methods 
During the period between December 2007 and August 2009, over 90 
membranes were fabricated.  Of those membranes that were tested, 24 
performed well enough to be used in further tests.  The result was a waste in 
time and resources and it would be useful to solve this problem before further 
related experiments are undertaken.  Several alterations to the fabrication 
method have been tested with limited success.  For example, while working on 
the membrane fabrication in a separate lab a switch in the anionic-repelling salt 
from KTpClB (potassium tetrakis (p‐chlorophenyl) borate) to KTTFPB was made 
due to the improved solubility in chloroform of the latter.  Although still 
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unexplained, this adjustment to the membrane’s composition seemed to help 
with the performance and the change was adopted permanently starting in May 
2008. 
5-2.2 Altering the culture conditions 
It is important to consider the variation in performance of Caco-2 cells due 
to laboratory conditions.  In these experiments a narrow range of passage was 
used (21-33), the same seeding cell density was used, the same media 
composition was used, the substrate was the same, and the period of time 
allowed for the cells to attach, spread, and organize remained constant (3 days).  
It may be of interest to consider the cell-based biosensor performance when 
other cell culture parameters are used.  A different range of cell passage number 
may result in, for example, better cell monolayer confluency upon seeding on the 
electrode membrane and thus more inhibition in the response of the control 
biosensor.  As discussed earlier, other types of media and substrates exist that 
may result in more rapid maturation and differentiation of a confluent cell 
monolayer.  If it is not possible to quicken the cell maturation, then one should 
consider an increase in the duration of time allotted for cell maturation to occur, 
being aware that a potential trade-off exists as the polymer membrane leaches 
active ingredients into the aqueous culture media with time.  
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5-2.3 Utilizing other epithelial cell lines 
Other epithelial cell lines have been used to study the permeability of 
particular solutes as well as the effects of permeability-altering substances.  
Some examples include T84, MDCK, and LLC-PK1. 
T84, like Caco-2, is a human adenocarcinoma cell line that has been well 
tested for its permeability properties but differs from Caco-2 in that it can form 
fully differentiated monolayers with 5 to 10 days post-seeding [60].  MDCK and 
LLC-PK1 can form monolayers ready for tests after three to six days of culturing, 
although MDCK generally demonstrates lower TEER values than Caco-2 cells 
and LLC-PK1 tends to absorb greater amounts of commonly tested compounds 
[61-63]. 
5-2.4 Exploring the mechanisms of permeability changes in cells 
  As previously mentioned, it is possible that some of the differences 
observed between the paracellular gap area screening method and the electrode 
test method could involve whether the pathway employed was paracellular or 
transcellular.  For verification of what pathways are being used to cause the 
changes in cell permeability of the cell-based biosensors, a study could be done.  
In another experiment [64] it was discovered that if p38 mitogen-activated protein 
kinase (p38 MAPK) was blocked with an inhibitor, SB203580, then cytomix was 
unable to disrupt the barrier function of Caco-2 cells in its usual manner.  Since 
p38 MAPK mediates the cell-to-cell junctions of epithelial cells [65], using this 
particular inhibitor could render the cytokines ineffective at causing permeability 
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changes at these junctions of the cells.  Any observed changes in electrode 
response would thus be indicative of a change in transcellular permeability.  
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List of Abbreviations 
 
ATCC  American Type Culture Collection 
bFGF   Basic Fibroblast Growth Factor 
CDI   Carbonyldiimidazole 
CTA  Cellulose Triacetate 
DMSO  Dimethyl sulfoxide 
EDTA  Ethylenediaminetetraacetic Acid 
EMF  Electromotive Force 
F-actin  Filamentous Actin  
FBS  Fetal Bovine Serum 
GRGDS  Glycine-Arginine-Glycine-Aspartic Acid-Serine 
HGF  Hepatocyte Growth Factor 
HIF-1  Hypoxia-Inducible Factor 
HUVECs  Human Umbilical-Vein Endothelial Cells 
KCl  Potassium Chloride 
KTpClB  Potassium Tetrakis (p‐Chlorophenyl) Borate 
KTTFPB  Tetrakis[3,5-bis(trifluoromethyl)phenyl]boron potassium  
MDCK  Madin-Darby Canine Kidney 
NaOH  Sodium Hydroxide 
NF-kB  Nuclear Factor Kappa B 
NPOE  2-Nitrophenyl Octyl Ether  
p38 MAPK  p38 Mitogen-Activated Protein Kinase 
PBS  Phosphate Buffered Saline Solution 
PFA  Paraformaldehyde 
P-gp  P-glycoprotein 
PVC  Polyvinyl Chloride 
pVHL  Von Hippel-Lindau Protein 
RGD  Arginine-Glycine-Aspartic Acid 
TNF-  Tumor Necrosis Factor Alpha 
TEER  Transepithelial Resistance 
 
Tg  Glass Transition Temperature 
TIFF  Tagged Image File Format 
 
VEGF  Vascular Endothelial Growth Factor 
VHL  Von Hippel-Lindau 
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